ArticleCellular and molecular neurobiology2026
HDAC Inhibition Reshapes Splicing of Synaptic Plasticity-Related Genes and Neural Network Dynamics.
Article in Cellular and molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Alternative splicing (AS) serves as a fundamental mechanism governing proteomic diversity in brain cells throughout development and adulthood, profoundly influencing cell differentiation and synaptic plasticity. In this study we used a model system of rat primary neuron cultures to examine how global chromatin remodeling induced by the broad-spectrum HDAC inhibitor trichostatin A (TSA) influences local AS patterns in plasticity-related genes and explored their possible functional implications for synaptic functioning. Analysis of transcriptomic data uncovered a widespread dynamic AS-induced changes in plasticity-related genes through both transcription-coupled and post-transcriptional mechanisms. We found that prolonged TSA treatment preferentially alters the exon composition in genes involved in synapse organization and signal transduction. Using quantitative PCR, we validated these results for selected genes encoding involved in synaptic functioning cell adhesion molecules (Nrxn1, Nrxn2), scaffold proteins (Shank2, Dlgap1), glutamate receptors (Gria4), and signaling molecules (Syngap1, Prkcz). To determine whether these molecular changes correlate with neural network activity, we performed calcium imaging in neuron cultures expressing the genetically encoded calcium sensor GCaMP6s. We found that molecular rearrangements accompanied the temporally delayed substantial network reorganization, which appeared at 19 h as an increased synchronization of neuronal activity, followed by elevated neuronal excitability at 48 h. These results establish a novel mechanistic link between epigenetic regulation, AS dynamics, and synaptic functioning, explaining how the HDAC inhibitors can enhance synaptic plasticity. Furthermore, our findings provide novel insights into molecular basis of neurological disorders associated with splicing dysregulation, offering new directions for therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.